nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—NR3C1—Mometasone—systemic scleroderma	0.339	0.434	CbGbCtD
Mifepristone—NR3C1—Prednisone—systemic scleroderma	0.108	0.138	CbGbCtD
Mifepristone—ABCB1—Lisinopril—systemic scleroderma	0.0533	0.0682	CbGbCtD
Mifepristone—ABCC1—Methotrexate—systemic scleroderma	0.0522	0.0669	CbGbCtD
Mifepristone—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0483	0.0618	CbGbCtD
Mifepristone—ABCB1—Captopril—systemic scleroderma	0.0399	0.0511	CbGbCtD
Mifepristone—CYP2D6—Captopril—systemic scleroderma	0.0376	0.0481	CbGbCtD
Mifepristone—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0314	0.0402	CbGbCtD
Mifepristone—ABCB1—Prednisone—systemic scleroderma	0.0251	0.0322	CbGbCtD
Mifepristone—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0188	0.0241	CbGbCtD
Mifepristone—CYP3A4—Prednisone—systemic scleroderma	0.0151	0.0193	CbGbCtD
Mifepristone—ABCB1—Methotrexate—systemic scleroderma	0.0126	0.0161	CbGbCtD
Mifepristone—PGR—artery—systemic scleroderma	0.000763	0.147	CbGeAlD
Mifepristone—PGR—blood vessel—systemic scleroderma	0.000594	0.115	CbGeAlD
Mifepristone—Anorexia—Leflunomide—systemic scleroderma	0.000438	0.00205	CcSEcCtD
Mifepristone—Nausea—Pentoxifylline—systemic scleroderma	0.000437	0.00205	CcSEcCtD
Mifepristone—Chills—Mycophenolate mofetil—systemic scleroderma	0.000437	0.00205	CcSEcCtD
Mifepristone—Malaise—Lisinopril—systemic scleroderma	0.000437	0.00205	CcSEcCtD
Mifepristone—Infection—Mycophenolic acid—systemic scleroderma	0.000436	0.00204	CcSEcCtD
Mifepristone—Diarrhoea—Mometasone—systemic scleroderma	0.000435	0.00204	CcSEcCtD
Mifepristone—Hypokalaemia—Prednisone—systemic scleroderma	0.000434	0.00204	CcSEcCtD
Mifepristone—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00043	0.00202	CcSEcCtD
Mifepristone—Hypotension—Leflunomide—systemic scleroderma	0.00043	0.00201	CcSEcCtD
Mifepristone—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000427	0.002	CcSEcCtD
Mifepristone—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000426	0.002	CcSEcCtD
Mifepristone—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000424	0.00199	CcSEcCtD
Mifepristone—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.000423	0.00198	CcSEcCtD
Mifepristone—Muscular weakness—Prednisone—systemic scleroderma	0.000421	0.00197	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00042	0.00197	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000419	0.00196	CcSEcCtD
Mifepristone—Anorexia—Mycophenolic acid—systemic scleroderma	0.000418	0.00196	CcSEcCtD
Mifepristone—Insomnia—Leflunomide—systemic scleroderma	0.000416	0.00195	CcSEcCtD
Mifepristone—Myalgia—Lisinopril—systemic scleroderma	0.000412	0.00193	CcSEcCtD
Mifepristone—Arthralgia—Lisinopril—systemic scleroderma	0.000412	0.00193	CcSEcCtD
Mifepristone—Anxiety—Lisinopril—systemic scleroderma	0.000411	0.00193	CcSEcCtD
Mifepristone—Back pain—Mycophenolate mofetil—systemic scleroderma	0.00041	0.00192	CcSEcCtD
Mifepristone—Dyspnoea—Leflunomide—systemic scleroderma	0.00041	0.00192	CcSEcCtD
Mifepristone—Hypotension—Mycophenolic acid—systemic scleroderma	0.00041	0.00192	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000409	0.00192	CcSEcCtD
Mifepristone—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000408	0.00191	CcSEcCtD
Mifepristone—Discomfort—Lisinopril—systemic scleroderma	0.000407	0.00191	CcSEcCtD
Mifepristone—Vomiting—Mometasone—systemic scleroderma	0.000404	0.00189	CcSEcCtD
Mifepristone—Dry mouth—Lisinopril—systemic scleroderma	0.000403	0.00189	CcSEcCtD
Mifepristone—Feeling abnormal—Azathioprine—systemic scleroderma	0.000401	0.00188	CcSEcCtD
Mifepristone—Rash—Mometasone—systemic scleroderma	0.0004	0.00188	CcSEcCtD
Mifepristone—Asthenia—Captopril—systemic scleroderma	0.0004	0.00188	CcSEcCtD
Mifepristone—Dermatitis—Mometasone—systemic scleroderma	0.0004	0.00188	CcSEcCtD
Mifepristone—Decreased appetite—Leflunomide—systemic scleroderma	0.0004	0.00187	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.0004	0.00187	CcSEcCtD
Mifepristone—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000398	0.00187	CcSEcCtD
Mifepristone—Headache—Mometasone—systemic scleroderma	0.000398	0.00187	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000397	0.00186	CcSEcCtD
Mifepristone—Insomnia—Mycophenolic acid—systemic scleroderma	0.000397	0.00186	CcSEcCtD
Mifepristone—Fatigue—Leflunomide—systemic scleroderma	0.000396	0.00186	CcSEcCtD
Mifepristone—Oedema—Lisinopril—systemic scleroderma	0.000395	0.00185	CcSEcCtD
Mifepristone—Pruritus—Captopril—systemic scleroderma	0.000395	0.00185	CcSEcCtD
Mifepristone—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000394	0.00185	CcSEcCtD
Mifepristone—Pain—Leflunomide—systemic scleroderma	0.000393	0.00184	CcSEcCtD
Mifepristone—Constipation—Leflunomide—systemic scleroderma	0.000393	0.00184	CcSEcCtD
Mifepristone—Infection—Lisinopril—systemic scleroderma	0.000392	0.00184	CcSEcCtD
Mifepristone—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000391	0.00183	CcSEcCtD
Mifepristone—Somnolence—Mycophenolic acid—systemic scleroderma	0.00039	0.00183	CcSEcCtD
Mifepristone—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000388	0.00182	CcSEcCtD
Mifepristone—Body temperature increased—Azathioprine—systemic scleroderma	0.000385	0.0018	CcSEcCtD
Mifepristone—Abdominal pain—Azathioprine—systemic scleroderma	0.000385	0.0018	CcSEcCtD
Mifepristone—Skin disorder—Lisinopril—systemic scleroderma	0.000384	0.0018	CcSEcCtD
Mifepristone—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000382	0.00179	CcSEcCtD
Mifepristone—Diarrhoea—Captopril—systemic scleroderma	0.000382	0.00179	CcSEcCtD
Mifepristone—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000381	0.00179	CcSEcCtD
Mifepristone—Feeling abnormal—Leflunomide—systemic scleroderma	0.000379	0.00178	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000379	0.00178	CcSEcCtD
Mifepristone—Fatigue—Mycophenolic acid—systemic scleroderma	0.000378	0.00177	CcSEcCtD
Mifepristone—Nausea—Mometasone—systemic scleroderma	0.000377	0.00177	CcSEcCtD
Mifepristone—Anorexia—Lisinopril—systemic scleroderma	0.000377	0.00177	CcSEcCtD
Mifepristone—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000376	0.00176	CcSEcCtD
Mifepristone—Pain—Mycophenolic acid—systemic scleroderma	0.000375	0.00176	CcSEcCtD
Mifepristone—Constipation—Mycophenolic acid—systemic scleroderma	0.000375	0.00176	CcSEcCtD
Mifepristone—Hypotension—Lisinopril—systemic scleroderma	0.000369	0.00173	CcSEcCtD
Mifepristone—Dizziness—Captopril—systemic scleroderma	0.000369	0.00173	CcSEcCtD
Mifepristone—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000366	0.00172	CcSEcCtD
Mifepristone—Urticaria—Leflunomide—systemic scleroderma	0.000365	0.00171	CcSEcCtD
Mifepristone—Abdominal pain—Leflunomide—systemic scleroderma	0.000363	0.0017	CcSEcCtD
Mifepristone—Body temperature increased—Leflunomide—systemic scleroderma	0.000363	0.0017	CcSEcCtD
Mifepristone—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000361	0.00169	CcSEcCtD
Mifepristone—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000361	0.00169	CcSEcCtD
Mifepristone—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000361	0.00169	CcSEcCtD
Mifepristone—Breast disorder—Methotrexate—systemic scleroderma	0.000361	0.00169	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00036	0.00169	CcSEcCtD
Mifepristone—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00036	0.00169	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000359	0.00168	CcSEcCtD
Mifepristone—Hypersensitivity—Azathioprine—systemic scleroderma	0.000359	0.00168	CcSEcCtD
Mifepristone—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000359	0.00168	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000359	0.00168	CcSEcCtD
Mifepristone—Insomnia—Lisinopril—systemic scleroderma	0.000357	0.00168	CcSEcCtD
Mifepristone—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000357	0.00167	CcSEcCtD
Mifepristone—Vomiting—Captopril—systemic scleroderma	0.000355	0.00166	CcSEcCtD
Mifepristone—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000353	0.00166	CcSEcCtD
Mifepristone—Dyspnoea—Lisinopril—systemic scleroderma	0.000352	0.00165	CcSEcCtD
Mifepristone—Rash—Captopril—systemic scleroderma	0.000352	0.00165	CcSEcCtD
Mifepristone—Dermatitis—Captopril—systemic scleroderma	0.000351	0.00165	CcSEcCtD
Mifepristone—Somnolence—Lisinopril—systemic scleroderma	0.000351	0.00165	CcSEcCtD
Mifepristone—Headache—Captopril—systemic scleroderma	0.000349	0.00164	CcSEcCtD
Mifepristone—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000347	0.00163	CcSEcCtD
Mifepristone—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000347	0.00163	CcSEcCtD
Mifepristone—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000346	0.00162	CcSEcCtD
Mifepristone—Infection—Mycophenolate mofetil—systemic scleroderma	0.000344	0.00161	CcSEcCtD
Mifepristone—Decreased appetite—Lisinopril—systemic scleroderma	0.000343	0.00161	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000341	0.0016	CcSEcCtD
Mifepristone—Fatigue—Lisinopril—systemic scleroderma	0.000341	0.0016	CcSEcCtD
Mifepristone—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000339	0.00159	CcSEcCtD
Mifepristone—Hypersensitivity—Leflunomide—systemic scleroderma	0.000339	0.00159	CcSEcCtD
Mifepristone—Pain—Lisinopril—systemic scleroderma	0.000338	0.00158	CcSEcCtD
Mifepristone—Constipation—Lisinopril—systemic scleroderma	0.000338	0.00158	CcSEcCtD
Mifepristone—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000336	0.00158	CcSEcCtD
Mifepristone—Diarrhoea—Azathioprine—systemic scleroderma	0.000333	0.00156	CcSEcCtD
Mifepristone—Haemoglobin—Prednisone—systemic scleroderma	0.000332	0.00156	CcSEcCtD
Mifepristone—Nausea—Captopril—systemic scleroderma	0.000331	0.00155	CcSEcCtD
Mifepristone—Haemorrhage—Prednisone—systemic scleroderma	0.00033	0.00155	CcSEcCtD
Mifepristone—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00033	0.00155	CcSEcCtD
Mifepristone—Asthenia—Leflunomide—systemic scleroderma	0.00033	0.00155	CcSEcCtD
Mifepristone—Feeling abnormal—Lisinopril—systemic scleroderma	0.000326	0.00153	CcSEcCtD
Mifepristone—Pruritus—Leflunomide—systemic scleroderma	0.000325	0.00153	CcSEcCtD
Mifepristone—Connective tissue disorder—Prednisone—systemic scleroderma	0.000325	0.00152	CcSEcCtD
Mifepristone—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000323	0.00152	CcSEcCtD
Mifepristone—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000323	0.00151	CcSEcCtD
Mifepristone—Dizziness—Azathioprine—systemic scleroderma	0.000322	0.00151	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000315	0.00148	CcSEcCtD
Mifepristone—Asthenia—Mycophenolic acid—systemic scleroderma	0.000315	0.00148	CcSEcCtD
Mifepristone—Diarrhoea—Leflunomide—systemic scleroderma	0.000315	0.00147	CcSEcCtD
Mifepristone—Urticaria—Lisinopril—systemic scleroderma	0.000314	0.00147	CcSEcCtD
Mifepristone—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000313	0.00147	CcSEcCtD
Mifepristone—Abdominal pain—Lisinopril—systemic scleroderma	0.000312	0.00146	CcSEcCtD
Mifepristone—Body temperature increased—Lisinopril—systemic scleroderma	0.000312	0.00146	CcSEcCtD
Mifepristone—Pruritus—Mycophenolic acid—systemic scleroderma	0.00031	0.00145	CcSEcCtD
Mifepristone—Vomiting—Azathioprine—systemic scleroderma	0.00031	0.00145	CcSEcCtD
Mifepristone—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000309	0.00145	CcSEcCtD
Mifepristone—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000308	0.00144	CcSEcCtD
Mifepristone—Infestation NOS—Methotrexate—systemic scleroderma	0.000307	0.00144	CcSEcCtD
Mifepristone—Infestation—Methotrexate—systemic scleroderma	0.000307	0.00144	CcSEcCtD
Mifepristone—Rash—Azathioprine—systemic scleroderma	0.000307	0.00144	CcSEcCtD
Mifepristone—Dermatitis—Azathioprine—systemic scleroderma	0.000307	0.00144	CcSEcCtD
Mifepristone—Headache—Azathioprine—systemic scleroderma	0.000305	0.00143	CcSEcCtD
Mifepristone—PGR—connective tissue—systemic scleroderma	0.000305	0.0589	CbGeAlD
Mifepristone—Dizziness—Leflunomide—systemic scleroderma	0.000304	0.00143	CcSEcCtD
Mifepristone—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000301	0.00141	CcSEcCtD
Mifepristone—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.0003	0.00141	CcSEcCtD
Mifepristone—Angiopathy—Prednisone—systemic scleroderma	0.0003	0.0014	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000299	0.0014	CcSEcCtD
Mifepristone—Pain—Mycophenolate mofetil—systemic scleroderma	0.000296	0.00139	CcSEcCtD
Mifepristone—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000296	0.00139	CcSEcCtD
Mifepristone—Vomiting—Leflunomide—systemic scleroderma	0.000292	0.00137	CcSEcCtD
Mifepristone—Hypersensitivity—Lisinopril—systemic scleroderma	0.000291	0.00136	CcSEcCtD
Mifepristone—Dizziness—Mycophenolic acid—systemic scleroderma	0.00029	0.00136	CcSEcCtD
Mifepristone—Rash—Leflunomide—systemic scleroderma	0.00029	0.00136	CcSEcCtD
Mifepristone—Dermatitis—Leflunomide—systemic scleroderma	0.00029	0.00136	CcSEcCtD
Mifepristone—Mental disorder—Prednisone—systemic scleroderma	0.000289	0.00136	CcSEcCtD
Mifepristone—Nausea—Azathioprine—systemic scleroderma	0.000289	0.00136	CcSEcCtD
Mifepristone—Headache—Leflunomide—systemic scleroderma	0.000288	0.00135	CcSEcCtD
Mifepristone—Malnutrition—Prednisone—systemic scleroderma	0.000287	0.00135	CcSEcCtD
Mifepristone—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000285	0.00134	CcSEcCtD
Mifepristone—Asthenia—Lisinopril—systemic scleroderma	0.000283	0.00133	CcSEcCtD
Mifepristone—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000283	0.00133	CcSEcCtD
Mifepristone—Pruritus—Lisinopril—systemic scleroderma	0.00028	0.00131	CcSEcCtD
Mifepristone—Vomiting—Mycophenolic acid—systemic scleroderma	0.000279	0.00131	CcSEcCtD
Mifepristone—PGR—smooth muscle tissue—systemic scleroderma	0.000279	0.0538	CbGeAlD
Mifepristone—Haemoglobin—Methotrexate—systemic scleroderma	0.000277	0.0013	CcSEcCtD
Mifepristone—Rash—Mycophenolic acid—systemic scleroderma	0.000277	0.0013	CcSEcCtD
Mifepristone—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000276	0.0013	CcSEcCtD
Mifepristone—Haemorrhage—Methotrexate—systemic scleroderma	0.000276	0.00129	CcSEcCtD
Mifepristone—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000275	0.00129	CcSEcCtD
Mifepristone—Headache—Mycophenolic acid—systemic scleroderma	0.000275	0.00129	CcSEcCtD
Mifepristone—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000274	0.00128	CcSEcCtD
Mifepristone—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000274	0.00128	CcSEcCtD
Mifepristone—Nausea—Leflunomide—systemic scleroderma	0.000273	0.00128	CcSEcCtD
Mifepristone—Diarrhoea—Lisinopril—systemic scleroderma	0.00027	0.00127	CcSEcCtD
Mifepristone—Ill-defined disorder—Prednisone—systemic scleroderma	0.000267	0.00125	CcSEcCtD
Mifepristone—Angioedema—Prednisone—systemic scleroderma	0.000263	0.00123	CcSEcCtD
Mifepristone—Dizziness—Lisinopril—systemic scleroderma	0.000261	0.00122	CcSEcCtD
Mifepristone—Nausea—Mycophenolic acid—systemic scleroderma	0.000261	0.00122	CcSEcCtD
Mifepristone—Malaise—Prednisone—systemic scleroderma	0.000259	0.00122	CcSEcCtD
Mifepristone—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000255	0.0012	CcSEcCtD
Mifepristone—Vomiting—Lisinopril—systemic scleroderma	0.000251	0.00118	CcSEcCtD
Mifepristone—Angiopathy—Methotrexate—systemic scleroderma	0.00025	0.00117	CcSEcCtD
Mifepristone—Rash—Lisinopril—systemic scleroderma	0.000249	0.00117	CcSEcCtD
Mifepristone—Dermatitis—Lisinopril—systemic scleroderma	0.000249	0.00117	CcSEcCtD
Mifepristone—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000249	0.00117	CcSEcCtD
Mifepristone—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000248	0.00116	CcSEcCtD
Mifepristone—Hypertension—Prednisone—systemic scleroderma	0.000248	0.00116	CcSEcCtD
Mifepristone—Chills—Methotrexate—systemic scleroderma	0.000248	0.00116	CcSEcCtD
Mifepristone—Headache—Lisinopril—systemic scleroderma	0.000247	0.00116	CcSEcCtD
Mifepristone—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000245	0.00115	CcSEcCtD
Mifepristone—Arthralgia—Prednisone—systemic scleroderma	0.000245	0.00115	CcSEcCtD
Mifepristone—Myalgia—Prednisone—systemic scleroderma	0.000245	0.00115	CcSEcCtD
Mifepristone—Anxiety—Prednisone—systemic scleroderma	0.000244	0.00114	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000243	0.00114	CcSEcCtD
Mifepristone—AR—connective tissue—systemic scleroderma	0.000243	0.0469	CbGeAlD
Mifepristone—Discomfort—Prednisone—systemic scleroderma	0.000242	0.00113	CcSEcCtD
Mifepristone—Mental disorder—Methotrexate—systemic scleroderma	0.000242	0.00113	CcSEcCtD
Mifepristone—Malnutrition—Methotrexate—systemic scleroderma	0.00024	0.00113	CcSEcCtD
Mifepristone—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000237	0.00111	CcSEcCtD
Mifepristone—Nausea—Lisinopril—systemic scleroderma	0.000235	0.0011	CcSEcCtD
Mifepristone—Oedema—Prednisone—systemic scleroderma	0.000235	0.0011	CcSEcCtD
Mifepristone—Infection—Prednisone—systemic scleroderma	0.000233	0.00109	CcSEcCtD
Mifepristone—Back pain—Methotrexate—systemic scleroderma	0.000232	0.00109	CcSEcCtD
Mifepristone—Nervous system disorder—Prednisone—systemic scleroderma	0.00023	0.00108	CcSEcCtD
Mifepristone—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000229	0.00107	CcSEcCtD
Mifepristone—Skin disorder—Prednisone—systemic scleroderma	0.000228	0.00107	CcSEcCtD
Mifepristone—Anorexia—Prednisone—systemic scleroderma	0.000224	0.00105	CcSEcCtD
Mifepristone—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000223	0.00105	CcSEcCtD
Mifepristone—AR—smooth muscle tissue—systemic scleroderma	0.000222	0.0429	CbGeAlD
Mifepristone—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00022	0.00103	CcSEcCtD
Mifepristone—AR—skin of body—systemic scleroderma	0.000219	0.0423	CbGeAlD
Mifepristone—Rash—Mycophenolate mofetil—systemic scleroderma	0.000218	0.00102	CcSEcCtD
Mifepristone—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000218	0.00102	CcSEcCtD
Mifepristone—Headache—Mycophenolate mofetil—systemic scleroderma	0.000217	0.00102	CcSEcCtD
Mifepristone—Malaise—Methotrexate—systemic scleroderma	0.000217	0.00102	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000214	0.001	CcSEcCtD
Mifepristone—Insomnia—Prednisone—systemic scleroderma	0.000212	0.000995	CcSEcCtD
Mifepristone—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000206	0.000964	CcSEcCtD
Mifepristone—Myalgia—Methotrexate—systemic scleroderma	0.000205	0.000959	CcSEcCtD
Mifepristone—Arthralgia—Methotrexate—systemic scleroderma	0.000205	0.000959	CcSEcCtD
Mifepristone—Decreased appetite—Prednisone—systemic scleroderma	0.000204	0.000956	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000203	0.000952	CcSEcCtD
Mifepristone—Fatigue—Prednisone—systemic scleroderma	0.000202	0.000948	CcSEcCtD
Mifepristone—Discomfort—Methotrexate—systemic scleroderma	0.000202	0.000948	CcSEcCtD
Mifepristone—Constipation—Prednisone—systemic scleroderma	0.000201	0.000941	CcSEcCtD
Mifepristone—Infection—Methotrexate—systemic scleroderma	0.000195	0.000913	CcSEcCtD
Mifepristone—Feeling abnormal—Prednisone—systemic scleroderma	0.000193	0.000907	CcSEcCtD
Mifepristone—Nervous system disorder—Methotrexate—systemic scleroderma	0.000192	0.000902	CcSEcCtD
Mifepristone—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000192	0.0009	CcSEcCtD
Mifepristone—Skin disorder—Methotrexate—systemic scleroderma	0.00019	0.000893	CcSEcCtD
Mifepristone—Anorexia—Methotrexate—systemic scleroderma	0.000187	0.000876	CcSEcCtD
Mifepristone—Urticaria—Prednisone—systemic scleroderma	0.000186	0.000874	CcSEcCtD
Mifepristone—Abdominal pain—Prednisone—systemic scleroderma	0.000185	0.00087	CcSEcCtD
Mifepristone—Body temperature increased—Prednisone—systemic scleroderma	0.000185	0.00087	CcSEcCtD
Mifepristone—PGR—lung—systemic scleroderma	0.000184	0.0355	CbGeAlD
Mifepristone—ABCB1—blood vessel—systemic scleroderma	0.000184	0.0355	CbGeAlD
Mifepristone—Hypotension—Methotrexate—systemic scleroderma	0.000183	0.000859	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000179	0.000838	CcSEcCtD
Mifepristone—Insomnia—Methotrexate—systemic scleroderma	0.000177	0.000832	CcSEcCtD
Mifepristone—NR3C1—connective tissue—systemic scleroderma	0.000176	0.034	CbGeAlD
Mifepristone—AR—digestive system—systemic scleroderma	0.000175	0.0339	CbGeAlD
Mifepristone—Dyspnoea—Methotrexate—systemic scleroderma	0.000175	0.00082	CcSEcCtD
Mifepristone—Somnolence—Methotrexate—systemic scleroderma	0.000174	0.000817	CcSEcCtD
Mifepristone—Hypersensitivity—Prednisone—systemic scleroderma	0.000173	0.000811	CcSEcCtD
Mifepristone—Decreased appetite—Methotrexate—systemic scleroderma	0.00017	0.000799	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000169	0.000794	CcSEcCtD
Mifepristone—Fatigue—Methotrexate—systemic scleroderma	0.000169	0.000793	CcSEcCtD
Mifepristone—Asthenia—Prednisone—systemic scleroderma	0.000168	0.000789	CcSEcCtD
Mifepristone—Pain—Methotrexate—systemic scleroderma	0.000168	0.000786	CcSEcCtD
Mifepristone—AR—tendon—systemic scleroderma	0.000167	0.0322	CbGeAlD
Mifepristone—Pruritus—Prednisone—systemic scleroderma	0.000166	0.000778	CcSEcCtD
Mifepristone—Feeling abnormal—Methotrexate—systemic scleroderma	0.000162	0.000758	CcSEcCtD
Mifepristone—NR3C1—smooth muscle tissue—systemic scleroderma	0.000161	0.0311	CbGeAlD
Mifepristone—Diarrhoea—Prednisone—systemic scleroderma	0.000161	0.000753	CcSEcCtD
Mifepristone—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00016	0.000752	CcSEcCtD
Mifepristone—NR3C1—skin of body—systemic scleroderma	0.000159	0.0307	CbGeAlD
Mifepristone—ABCC1—tendon—systemic scleroderma	0.000158	0.0306	CbGeAlD
Mifepristone—Urticaria—Methotrexate—systemic scleroderma	0.000156	0.00073	CcSEcCtD
Mifepristone—Dizziness—Prednisone—systemic scleroderma	0.000155	0.000727	CcSEcCtD
Mifepristone—Body temperature increased—Methotrexate—systemic scleroderma	0.000155	0.000727	CcSEcCtD
Mifepristone—Abdominal pain—Methotrexate—systemic scleroderma	0.000155	0.000727	CcSEcCtD
Mifepristone—Vomiting—Prednisone—systemic scleroderma	0.000149	0.000699	CcSEcCtD
Mifepristone—Rash—Prednisone—systemic scleroderma	0.000148	0.000694	CcSEcCtD
Mifepristone—Dermatitis—Prednisone—systemic scleroderma	0.000148	0.000693	CcSEcCtD
Mifepristone—Headache—Prednisone—systemic scleroderma	0.000147	0.000689	CcSEcCtD
Mifepristone—AR—lung—systemic scleroderma	0.000146	0.0283	CbGeAlD
Mifepristone—Hypersensitivity—Methotrexate—systemic scleroderma	0.000144	0.000677	CcSEcCtD
Mifepristone—Asthenia—Methotrexate—systemic scleroderma	0.000141	0.00066	CcSEcCtD
Mifepristone—Nausea—Prednisone—systemic scleroderma	0.000139	0.000653	CcSEcCtD
Mifepristone—ABCC1—lung—systemic scleroderma	0.000139	0.0269	CbGeAlD
Mifepristone—Pruritus—Methotrexate—systemic scleroderma	0.000139	0.00065	CcSEcCtD
Mifepristone—Diarrhoea—Methotrexate—systemic scleroderma	0.000134	0.000629	CcSEcCtD
Mifepristone—Dizziness—Methotrexate—systemic scleroderma	0.00013	0.000608	CcSEcCtD
Mifepristone—CYP3A5—digestive system—systemic scleroderma	0.000128	0.0247	CbGeAlD
Mifepristone—NR3C1—digestive system—systemic scleroderma	0.000127	0.0245	CbGeAlD
Mifepristone—Vomiting—Methotrexate—systemic scleroderma	0.000125	0.000585	CcSEcCtD
Mifepristone—Rash—Methotrexate—systemic scleroderma	0.000124	0.00058	CcSEcCtD
Mifepristone—Dermatitis—Methotrexate—systemic scleroderma	0.000124	0.000579	CcSEcCtD
Mifepristone—Headache—Methotrexate—systemic scleroderma	0.000123	0.000576	CcSEcCtD
Mifepristone—NR3C1—tendon—systemic scleroderma	0.000121	0.0233	CbGeAlD
Mifepristone—Nausea—Methotrexate—systemic scleroderma	0.000116	0.000546	CcSEcCtD
Mifepristone—CYP3A5—lung—systemic scleroderma	0.000107	0.0206	CbGeAlD
Mifepristone—NR3C1—lung—systemic scleroderma	0.000106	0.0205	CbGeAlD
Mifepristone—CYP3A4—digestive system—systemic scleroderma	9.6e-05	0.0186	CbGeAlD
Mifepristone—CYP2D6—digestive system—systemic scleroderma	9.45e-05	0.0183	CbGeAlD
Mifepristone—ABCB1—digestive system—systemic scleroderma	6.8e-05	0.0131	CbGeAlD
Mifepristone—ABCB1—lung—systemic scleroderma	5.68e-05	0.011	CbGeAlD
